首页> 外文期刊>Stem Cell Research & Therapy >Bone marrow concentrate-induced mesenchymal stem cell conditioned medium facilitates wound healing and prevents hypertrophic scar formation in a rabbit ear model
【24h】

Bone marrow concentrate-induced mesenchymal stem cell conditioned medium facilitates wound healing and prevents hypertrophic scar formation in a rabbit ear model

机译:骨髓浓缩液诱导的间充质干细胞条件培养基促进伤口愈合并防止兔耳模型中增生性瘢痕形成

获取原文
           

摘要

Hypertrophic scars (HSs) are formed via an aberrant response to the wound healing process. HSs can be cosmetic or can result in functional problems. Prolonged proliferation and remodeling phases disrupt wound healing, leading to excessive collagen production and HS formation. However, there are currently no satisfactory drugs to prevent HS formation. Mesenchymal stem cell (MSC) conditioned medium (CM) has therapeutic effects on wound healing and preventing HS formation. Bone marrow concentrate (BMC) contains various growth factors and cytokines that are crucial for regeneration and has been applied in the clinical setting. In this study, we evaluated the effects of BMC-induced MSC CM on HS formation in a rabbit ear model. We established a rabbit ear wound model by generating full-thickness wounds in the ears of rabbits (n?=?12) and treated wounds with MSC CM, BMC CM, or BMC-induced MSC CM. Dermal fibroblasts from human hypertrophic scar were stimulated with transforming growth factor beta 1 (TGF-β1) for 24?h and cultured in each culture medium for 72?h. We measured the hypertrophic scar (HS) formation during the skin regeneration by measuring the expression of several remodeling molecules and the effect of these conditioned media on active human HS fibroblasts. Our results showed that BMC-induced MSC CM had greater antifibrotic effects than MSC CM and BMC CM significantly attenuated HS formation in rabbits. BMC-induced MSC CM accelerated wound re-epithelization by increasing cell proliferation. Additionally, BMC-induced MSC CM also inhibited fibrosis by decreasing profibrotic gene and protein expression, promoting extracellular matrix turnover, inhibiting fibroblast contraction, and reversing myofibroblast activation. BMC-induced MSC CM modulated the proliferation and remodeling phases of wound healing, representing a potential wound healing agent and approach for preventing HS formation.
机译:增生性疤痕(HSs)是通过对伤口愈合过程的异常反应形成的。 HS可能是化妆品,也可能导致功能问题。延长的增殖和重塑阶段破坏伤口愈合,导致胶原蛋白过多生成和HS形成。但是,目前尚没有令人满意的药物可以预防HS的形成。间充质干细胞(MSC)条件培养基(CM)对伤口愈合和预防HS形成具有治疗作用。骨髓浓缩液(BMC)包含各种对于再生至关重要的生长因子和细胞因子,已应用于临床。在这项研究中,我们评估了BMC诱导的MSC CM对兔耳模型中HS形成的影响。我们通过在兔子的耳朵上产生全层伤口(n≥12)并用MSC CM,BMC CM或BMC诱导的MSC CM处理伤口来建立兔耳伤口模型。用转化生长因子β1(TGF-β1)刺激人肥厚性瘢痕的皮肤成纤维细胞24?h,并在每种培养基中培养72?h。我们通过测量几种重塑分子的表达以及这些条件培养基对活跃的人类HS成纤维细胞的作用,在皮肤再生过程中测量了肥厚性瘢痕(HS)的形成。我们的结果表明,BMC诱导的MSC CM比MSC CM具有更大的抗纤维化作用,BMC CM显着减弱了兔的HS形成。 BMC诱导的MSC CM通过增加细胞增殖来加速伤口的再上皮形成。此外,BMC诱导的MSC CM还通过降低纤维化基因和蛋白质表达,促进细胞外基质更新,抑制成纤维细胞收缩和逆转成纤维细胞活化来抑制纤维化。 BMC诱导的MSC CM调节伤口愈合的增殖和重塑阶段,代表了潜在的伤口愈合剂和防止HS形成的方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号